A Study of TAK-227 in Healthy Adults

计划入组 24 人 · 首次发布于 2023 年 4 月 19 日

A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

计划入组 70 人 · 首次发布于 2025 年 3 月 19 日

GSK BHR Study (Sont)

计划入组 464 人 · 首次发布于 2009 年 6 月 15 日

GSK-2276186

AD-227

FKC-227

Gsk Consumer Healthcare Sarl

Denmark

GlaxoSmithKline

United Kingdom

GLAXOSMITHKLINE TRADING SERVICES LIMITED

Spain

GSK's GSK'227 Receives FDA Breakthrough Therapy Designation for Relapsed Osteosarcoma

GSK's B7-H3-Targeted ADC, GSK'227, Receives FDA Breakthrough Therapy Designation for Osteosarcoma

GSK's Cancer Portfolio Gains Momentum with Regulatory Successes for Dostarlimab and GSK'227